CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients
Clinical trial NCT06811727 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06811727
- Sponsor
- Ivan Šitum, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.